A carregar...

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene

BACKGROUND: The EML4‐ALK fusion gene has recently been identified as a driver mutation in a subset of non‐small cell lung cancers. In subsequent studies, EML4‐ALK has been detected in a low percentage of patients, and was associated with a lack of EGFR or KRAS mutations, younger age, and adenocarcin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Kometani, Takuro, Sugio, Kenji, Osoegawa, Atsushi, Seto, Takashi, Ichinose, Yukito
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928374/
https://ncbi.nlm.nih.gov/pubmed/29517858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12616
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!